Tipranavir low dose

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

HIV InfectionsHealthy

Phase 1

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

TerminatedNCT02245438

Boehringer IngelheimHealthy

Start: 2002-05-31Updated: 2014-09-19

Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers

CompletedNCT02251145

Boehringer IngelheimHealthy

Start: 2002-05-31Updated: 2014-09-29

Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects

CompletedNCT02251223

Boehringer IngelheimHIV Infections

Start: 2001-02-28Updated: 2014-09-29

Phase 2

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

CompletedNCT02238314

Boehringer IngelheimHIV Infections

Start: 1999-01-31Updated: 2014-09-12